We noticed you're blocking ads.

Keep supporting great journalism by turning off your ad blocker.

Questions about why you are seeing this? Contact us

Font Size

- Aa +

Wed 6 Apr 2016 12:55 PM

Font Size

- Aa +

Allergan-Pfizer deal in doubt

Pfizer is leaning towards abandoning its $160 billion merger deal with Allergan.

Allergan-Pfizer deal in doubt
(Getty Images)

If the deal collapses, analysts say, both companies could pursue other acquisitions.

(Source: Reuters YouTube channel)